Shares of Johnson Matthey PLC (LON:JMAT - Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,658.99 ($22.36) and traded as high as GBX 2,038 ($27.47). Johnson Matthey shares last traded at GBX 2,034.16 ($27.42), with a volume of 210,705 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank lifted their price objective on shares of Johnson Matthey from GBX 1,800 to GBX 1,950 and gave the stock a "hold" rating in a research report on Monday, July 21st. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of GBX 1,875.
View Our Latest Research Report on Johnson Matthey
Johnson Matthey Stock Performance
The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The company has a market capitalization of £3.40 billion, a PE ratio of 960.84, a PEG ratio of 49,242.50 and a beta of 0.95. The business has a 50 day simple moving average of GBX 1,889.33 and a 200 day simple moving average of GBX 1,658.99.
Insider Buying and Selling
In related news, insider Andrew Cosslett bought 10,495 shares of the company's stock in a transaction on Tuesday, August 26th. The shares were bought at an average price of GBX 1,896 per share, with a total value of £198,985.20. 0.50% of the stock is owned by company insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.